WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Mick Broad has taken part in research by Manchester's Royal Northern School of Music (RNCM) into the way music can support ...

Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...

"I waited this long to tell you about the diagnosis because I needed time to process the unsettling news myself," "Walking in Memphis" singer Marc Cohn wrote, adding that he wants to continue ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

Doctors and researchers say ping pong can help slow Parkinson's disease. The South County Recreation Center in Bixby hosts ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson’s, finds a new study led by UCL researchers.